122 related articles for article (PubMed ID: 17001479)
1. Localized Castleman's disease associated with systemic AA amyloidosis. Regression of amyloid deposits after tumor removal.
Androulaki A; Giaslakiotis K; Giakoumi X; Aessopos A; Lazaris AC
Ann Hematol; 2007 Jan; 86(1):55-7. PubMed ID: 17001479
[No Abstract] [Full Text] [Related]
2. Histopathological regression of systemic AA amyloidosis after surgical treatment of a localized Castleman's disease.
Shimojima Y; Takei Y; Tazawa K; Gono T; Fushimi T; Matsuda M; Hoshii Y; Ikeda S
Amyloid; 2006 Sep; 13(3):184-6. PubMed ID: 17062386
[TBL] [Abstract][Full Text] [Related]
3. Renal AA amyloidosis in a Castleman's disease patient.
Caro-Cuenca MT; Ortega-Salas R; Espinosa-Hernández M
Nefrologia; 2012; 32(5):699-700. PubMed ID: 23013971
[No Abstract] [Full Text] [Related]
4. Remission of nephrotic syndrome due to AA amyloidosis and initiation of glomerular repair after surgical resection of localized Castleman's disease.
Mandreoli M; Casanova S; Vianelli N; Pasquali S; Zucchelli P
Nephron; 2002 Mar; 90(3):336-40. PubMed ID: 11867955
[TBL] [Abstract][Full Text] [Related]
5. Secondary amyloidosis in Castleman's disease: review of the literature and report of a case.
Altiparmak MR; Pamuk GE; Pamuk ON; Doğusoy G
Ann Hematol; 2002 Jun; 81(6):336-9. PubMed ID: 12107565
[TBL] [Abstract][Full Text] [Related]
6. Localized Castleman's disease and nephrotic syndrome not responsive to resection plus colchicine therapy.
Derici U; Arinsoy T; Ataoglu O; Bali M; Eroglu A; Goker B; Sindel S
Ann Hematol; 2002 Jul; 81(7):399-401. PubMed ID: 12185513
[TBL] [Abstract][Full Text] [Related]
7. A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody.
Gholam D; Vantelon JM; Al-Jijakli A; Bourhis JH
Ann Hematol; 2003 Dec; 82(12):766-8. PubMed ID: 12898190
[TBL] [Abstract][Full Text] [Related]
8. [Castleman's disease and amyloidosis].
Olivares Martín J; Rivera Hernández F
Med Clin (Barc); 1990 Jun; 95(3):119. PubMed ID: 2250524
[No Abstract] [Full Text] [Related]
9. [A 21-year-old male patient with nephrotic syndrome and "idiopathic" AA amyloidosis].
Saura IM; Carretón A; López Guillén E; Alegría MS; Jimeno García L; Ferri B
Nefrologia; 2004; 24 Suppl 3():109-12. PubMed ID: 15219083
[TBL] [Abstract][Full Text] [Related]
10. Localised plasma-cell type Castleman's disease and AA-amyloidosis cured by resection. A case report and review of the literature.
Verbrugghe W; Maes BD; Knockaert DC
Acta Clin Belg; 2005; 60(1):22-7. PubMed ID: 15981701
[TBL] [Abstract][Full Text] [Related]
11. Marked hepatomegaly due to AA type amyloidosis in a case with Castleman's disease.
Yamagata N; Fujio J; Hirai R; Matsumaru M; Tanimura S; Inokuchi C; Shikai T; Takezako N; Nasu M; Sakata Y; Sata N; Nagai H; Saito K; Miwa A
Int J Hematol; 2006 Jul; 84(1):70-3. PubMed ID: 16867906
[TBL] [Abstract][Full Text] [Related]
12. Amyloid goiter with hypothyroidism.
Kanoh T; Shimada H; Uchino H; Matsumura K
Arch Pathol Lab Med; 1989 May; 113(5):542-4. PubMed ID: 2712679
[TBL] [Abstract][Full Text] [Related]
13. Posterior mediastinal localization of Castleman's disease: report of a case.
Erdogan A; Eser I; Ozbilim G
Surg Today; 2004; 34(9):772-3. PubMed ID: 15338352
[TBL] [Abstract][Full Text] [Related]
14. Angiofollicular lymph node hyperplasia resembling a spinal nerve sheath tumor: a rare case of Castleman's disease.
Stevens EA; Strowd RE; Mott RT; Oaks TE; Wilson JA
Spine J; 2009 Sep; 9(9):e18-22. PubMed ID: 19482516
[TBL] [Abstract][Full Text] [Related]
15. Giant mass due to Castleman's disease causing superior vena cava syndrome.
Tekinbas C; Erol MM; Ozsu S; Cobanoglu U; Kosucu P
Thorac Cardiovasc Surg; 2008 Aug; 56(5):303-5. PubMed ID: 18615381
[TBL] [Abstract][Full Text] [Related]
16. Multicentric Castleman's disease complicated by secondary renal amyloidosis.
Leung KT; Wong KM; Choi KS; Chau KF; Li CS
Nephrology (Carlton); 2004 Dec; 9(6):392-3. PubMed ID: 15663642
[No Abstract] [Full Text] [Related]
17. Multidisciplinary approach to the treatment of cardiac AA amyloidosis and aortic stenosis due to Castleman's disease: a hybrid therapy with tocilizumab and aortic valve replacement.
Shirakawa K; Egashira T; Ieda M; Kawaguchi S; Okamoto K; Kudo M; Yokoyama K; Tsuruta H; Murata M; Mikami S; Anzai A; Hayashida K; Kohno T; Maekawa Y; Sano M; Yozu R; Fukuda K
Int J Cardiol; 2014 May; 173(2):e9-e11. PubMed ID: 24681024
[No Abstract] [Full Text] [Related]
18. A case of multicentric Castleman's disease associated with renal amyloidosis and pure red cell aplasia.
Funabiki K; Kaneko S; Terajima M; Tomita H; Kawano Y; Tomino Y
Am J Nephrol; 1998; 18(3):247-50. PubMed ID: 9627044
[TBL] [Abstract][Full Text] [Related]
19. [Systemic AA amyloidosis induced by benign neoplasms].
Bestard Matamoros O; Poveda Monje R; Ibernon Vilaró M; Carrera Plans M; Grinyó Boira JM
Nefrologia; 2008; 28(1):93-8. PubMed ID: 18336138
[TBL] [Abstract][Full Text] [Related]
20. Retroperitoneal Castleman's tumor and paraneoplastic pemphigus: report of a case and review of the literature.
Menenakos C; Braumann C; Hartmann J; Jacobi CA
World J Surg Oncol; 2007 Apr; 5():45. PubMed ID: 17466075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
